Cohance Lifesciences Limited
COHANCE
Kedudukan dalam Saham
#6351
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Harga Saham
$5.09
Modal Pasaran
$1.95B
Perubahan (1 hari)
0.79%
Perubahan (1 tahun)
-57.04%
Negara
IN
Perdagangan Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Hasil untuk Cohance Lifesciences Limited (COHANCE)
Hasil pada Jun 2025 TTM: $176.91M
Menurut laporan kewangan terkini daripada Cohance Lifesciences Limited, hasil semasa syarikat (TTM) ialah $176.91M. Pada tahun 2024, syarikat memperoleh hasil sebanyak $126.09M penurunan berbanding hasil pada tahun 2023 iaitu $163.10M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Cohance Lifesciences Limited dari 2019 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $176.91M | 26.34% |
| 2025 | $140.02M | 11.05% |
| 2024 | $126.09M | -22.69% |
| 2023 | $163.10M | -4.01% |
| 2022 | $169.91M | 26.93% |
| 2021 | $133.86M | 24.97% |
| 2020 | $107.11M | 103.08% |
| 2019 | $52.74M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 3,637.27% |
IN
|
